{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:22:22Z","timestamp":1793406142334,"version":"4.5.0"},"reference-count":126,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Oradea, Romania"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background: Aortic stenosis (AS) has long been considered a degenerative disease and is typically diagnosed in older men at an advanced stage. However, accumulating evidence has highlighted the similarities between AS and atherosclerosis, particularly regarding shared risk factors and overlapping pathophysiological mechanisms. This connection has led to a paradigm shift, suggesting that AS may be preventable in its early stages. Methods: This narrative review synthesizes the existing literature exploring the parallels between AS and atherosclerosis, focusing on common risk factors, pathogenic pathways, and evolving therapeutic strategies. Clinical trials and translational studies were examined to assess the effectiveness of atherosclerosis-based treatments for AS. Results: Multiple studies have confirmed the shared inflammatory, lipid-mediated, and calcific mechanisms of AS and atherosclerosis. Despite these similarities, therapeutic strategies effective in atherosclerosis, such as statin therapy, have not consistently shown benefits in AS. New medical approaches aim to delay aortic valve replacement and reduce the associated morbidity. The partially overlapping pathogenesis continues to guide future research. Conclusions: While AS and atherosclerosis share several pathogenic features, their clinical courses and treatment responses diverge. Understanding the limits and potential of their overlap may inform future preventive and therapeutic strategies. Earlier detection and targeted intervention in AS remain key goals, drawing on insights from cardiovascular disease management.<\/jats:p>","DOI":"10.3390\/medicina61081375","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T07:37:23Z","timestamp":1753861043000},"page":"1375","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Unraveling the Link Between Aortic Stenosis and Atherosclerosis: What Have We Learned?"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0855-938X","authenticated-orcid":false,"given":"Corina","family":"Cinezan","sequence":"first","affiliation":[{"name":"Department of Medical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania"},{"name":"Clinical County Emergency Hospital Bihor, 410169 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9229-2656","authenticated-orcid":false,"given":"Camelia Bianca","family":"Rus","sequence":"additional","affiliation":[{"name":"Department of Medical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania"},{"name":"Clinical County Emergency Hospital Bihor, 410169 Oradea, Romania"},{"name":"Doctoral School of Biological and Biomedical Sciences, University of Oradea, 410087 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana Tiberia","family":"Ilias","sequence":"additional","affiliation":[{"name":"Department of Medical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania"},{"name":"Clinical County Emergency Hospital Bihor, 410169 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.jacc.2012.02.093","article-title":"Calcific aortic stenosis: A disease of the valve and the myocardium","volume":"60","author":"Dweck","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_2","unstructured":"Libby, P., Bonow, R.O., Mann, D.L., Tomaselli, G.F., Bhatt, D.L., Solomon, S.D., and Braunwald, E. (2022). Aortic valve stenosis. Braunwald\u2019s Heart Disease: A Textbook of Cardiovascular Medicine, Elsevier Saunders. [12th ed.]."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1136\/hrt.2004.057117","article-title":"Aortic sclerosis: Not an innocent murmur but a marker of increased cardiovascular risk","volume":"91","author":"Nightingale","year":"2005","journal-title":"Heart"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJM199907153410302","article-title":"Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly","volume":"341","author":"Otto","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_5","first-page":"31","article-title":"Management of asymptomatic valvular aortic stenosis","volume":"54","author":"Freeman","year":"2002","journal-title":"Indian Heart J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1016\/j.jacc.2014.04.018","article-title":"The prevalence, incidence, progression, and risks of aortic valve sclerosis: A systematic review and meta-analysis","volume":"63","author":"Coffey","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0735-1097(01)01705-3","article-title":"Progression of human aortic valve stenosis is associated with tenascin-C expression","volume":"39","author":"Satta","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1681\/ASN.V1291927","article-title":"Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients","volume":"12","author":"Wang","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/0735-1097(94)90606-8","article-title":"Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves","volume":"23","author":"Olsson","year":"1994","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1161\/01.CIR.92.8.2163","article-title":"Osteopontin is expressed in human aortic valvular lesions","volume":"92","author":"Kuusisto","year":"1995","journal-title":"Circulation"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1056\/NEJM200008313430910","article-title":"Aortic stenosis--listen to the patient, look at the valve","volume":"343","author":"Otto","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"16006","DOI":"10.1038\/nrdp.2016.6","article-title":"Calcific aortic stenosis","volume":"2","author":"Lindman","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_13","unstructured":"Libby, P., Bonow, R.O., Mann, D.L., Tomaselli, G.F., Bhatt, D.L., Solomon, S.D., and Braunwald, E. (2022). The Vascular Biology of Atherosclerosis. Braunwald\u2019s Heart Disease: A Textbook of Cardiovascular Medicine, Elsevier Saunders. [12th ed.]."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1172\/JCI4829","article-title":"Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase","volume":"103","author":"Feron","year":"1999","journal-title":"J. Clin. Investig."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1177\/002215540205000503","article-title":"Localization of caveolin 1 in aortic valve endothelial cells using antigen retrieval","volume":"50","author":"Rajamannan","year":"2002","journal-title":"J. Histochem. Cytochem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1136\/hrt.78.5.475","article-title":"A case-control investigation of the relation between hyperlipidaemia and calcific aortic valve stenosis","volume":"78","author":"Wilmshurst","year":"1997","journal-title":"Heart"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/hrt.78.5.472","article-title":"Cardiac valve calcification: Characteristics of patients with calcification of the mitral annulus or aortic valve","volume":"78","author":"Boon","year":"1997","journal-title":"Heart"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/heart.85.6.601","article-title":"Why is there discordance between calcific aortic stenosis and coronary artery disease?","volume":"85","author":"Otto","year":"2001","journal-title":"Heart"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1136\/hrt.2004.056614","article-title":"Are angiotensin converting enzyme inhibitors beneficial in patients with aortic stenosis?","volume":"91","author":"Shavelle","year":"2005","journal-title":"Heart"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0735-1097(03)00786-1","article-title":"Is aortic stenosis a preventable disease?","volume":"42","author":"Chan","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3949\/ccjm.70.5.471","article-title":"Calcific aortic stenosis: Another face of atherosclerosis?","volume":"70","author":"Novaro","year":"2003","journal-title":"Clevel. Clin. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0021-9681(84)90108-5","article-title":"Diabetes and hypercholesterolemia among patients with calcific aortic stenosis","volume":"37","author":"Deutscher","year":"1984","journal-title":"J. Chronic Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1076-7460.2001.00839.x","article-title":"Smoking and obesity are associated with the progression of aortic stenosis","volume":"10","author":"Ngo","year":"2001","journal-title":"Am. J. Geriatr. Cardiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1109034","article-title":"CHARGE Extracoronary Calcium Working Group. Genetic associations with valvular calcification and aortic stenosis","volume":"368","author":"Thanassoulis","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/CIRCGENETICS.113.000400","article-title":"Lipoprotein(a) levels, genotype, and incident aortic valve stenosis: A prospective Mendelian randomization study and replication in a case-control cohort","volume":"7","author":"Arsenault","year":"2014","journal-title":"Circ. Cardiovasc. Genet."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cjco.2019.03.004","article-title":"Lipoprotein(a), oxidized phospholipids, and aortic valve microcalcification assessed by 18F-sodium fluoride positron emission tomography and computed tomography","volume":"1","author":"Perrot","year":"2019","journal-title":"CJC Open"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/heartjnl-2021-319804","article-title":"Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis","volume":"108","author":"Kaiser","year":"2022","journal-title":"Heart"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.jacc.2019.01.070","article-title":"Lipoprotein(a) and oxidized phospholipids promote valve calcification in patients with aortic stenosis","volume":"73","author":"Zheng","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Schnitzler, J.G., Ali, L., Groenen, A.G., Kaiser, Y., and Kroon, J. (2019). Lipoprotein(a) as Orchestrator of Calcific Aortic Valve Stenosis. Biomolecules, 9.","DOI":"10.3390\/biom9120760"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/MOL.0000000000000681","article-title":"Lipoprotein(a): Is it more, less or equal to LDL as a causal factor for cardiovascular disease and mortality?","volume":"31","author":"Langsted","year":"2020","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/ATVBAHA.116.308761","article-title":"Oxidized phospholipids and risk of calcific aortic valve disease: The Copenhagen General Population Study","volume":"37","author":"Kamstrup","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1093\/eurheartj\/ehaa172","article-title":"Triglycerides and remnant cholesterol associated with risk of aortic valve stenosis: Mendelian randomization in the Copenhagen General Population Study","volume":"41","author":"Kaltoft","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e002711","DOI":"10.1161\/CIRCGEN.119.002711","article-title":"INVENT consortium. Genetic Determinants of Lipids and Cardiovascular Disease Outcomes: A Wide-Angled Mendelian Randomization Investigation","volume":"12","author":"Allara","year":"2019","journal-title":"Circ. Genom. Precis. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.hlc.2020.12.005","article-title":"Elevated Apolipoprotein B\/A-1 Ratio is Associated With an Increased Risk of Aortic Stenosis: Experience From the AMORIS Cohort","volume":"30","author":"Ivert","year":"2021","journal-title":"Heart Lung Circ."},{"key":"ref_35","first-page":"371","article-title":"Experimental hypercholesterolemia induces apoptosis in the aortic valve","volume":"10","author":"Rajamannan","year":"2001","journal-title":"J. Heart Valve Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0735-1097(03)00090-1","article-title":"Experimental aortic valve stenosis in rabbits","volume":"41","author":"Drolet","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1385\/BTER:91:2:97","article-title":"Interactions between Chlamydia pneumoniae and trace elements: A possible link to aortic valve sclerosis","volume":"91","author":"Lindh","year":"2003","journal-title":"Biol. Trace Elem. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0195-668X(02)00385-8","article-title":"Lipoprotein(a), Chlamydia pneumoniae, leptin and tissue plasminogen activator as risk markers for valvular aortic stenosis","volume":"24","author":"Glader","year":"2003","journal-title":"Eur. Heart J."},{"key":"ref_39","unstructured":"Libby, P., Bonow, R.O., Mann, D.L., Tomaselli, G.F., Bhatt, D.L., Solomon, S.D., and Braunwald, E. (2005). Risk Factors for Atherothrombotic Disease. Braunwald\u2019s Heart Disease: A Textbook of Cardiovascular Medicine, Elsevier Saunders. [12th ed.]."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.atherosclerosis.2004.01.028","article-title":"Inflammation, infection, and aortic valve sclerosis; Insights from the Olmsted County (Minnesota) population","volume":"174","author":"Agmon","year":"2004","journal-title":"Atherosclerosis"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1136\/heart.89.9.1019","article-title":"Cardiovascular risk factors in patients with aortic stenosis predict prevalence of coronary artery disease but not of aortic stenosis: An angiographic pair matched case-control study","volume":"89","author":"Ortlepp","year":"2003","journal-title":"Heart"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1161\/hc4101.097527","article-title":"Progression of aortic valve calcification: Association with coronary atherosclerosis and cardiovascular risk factors","volume":"104","author":"Pohle","year":"2001","journal-title":"Circulation"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ihj.2015.07.033","article-title":"Calcific aortic valve disease: Is it another face of atherosclerosis?","volume":"67","author":"Sathyamurthy","year":"2015","journal-title":"Indian Heart J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1161\/CIRCULATIONAHA.104.486738","article-title":"Spectrum of calcific aortic valve disease: Pathogenesis, disease progression and treatment strategies","volume":"111","author":"Freeman","year":"2005","journal-title":"Circulation"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s43044-023-00345-6","article-title":"Aortic stenosis: A review on acquired pathogenesis and ominous combination with diabetes mellitus","volume":"75","author":"Wal","year":"2023","journal-title":"Egypt Heart J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000486363","article-title":"The aortic stenosis complex","volume":"140","author":"Boudoulas","year":"2018","journal-title":"Cardiology"},{"key":"ref_47","unstructured":"Centers for Disease Control and Prevention (2011). Prevalence of coronary heart disease\u2014United States 2006\u20132010. MMWR Morb. Mortal. Wkly. Rep., 60, 1377\u20131381."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000354221","article-title":"Etiology of valvular heart disease in the 21st century","volume":"126","author":"Boudoulas","year":"2013","journal-title":"Cardiology"},{"key":"ref_49","unstructured":"Boudoulas, H. (2009). Valve disease. ACCSAP Version 7: Adult Clinical Cardiology Self-Assessment Program, American College of Cardiology Foundation. Chapter 19."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/CIRCGENETICS.112.962894","article-title":"Genetic basis of familial valvular heart disease","volume":"5","author":"Padang","year":"2012","journal-title":"Circ. Cardiovasc. Genet."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1161\/01.ATV.17.3.547","article-title":"Detection of osteopontin in calcified human aortic valves","volume":"17","author":"Mohler","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/108155890405200334","article-title":"Hemodynamic effects of the angiotensin-converting enzyme inhibitor, ramipril, in patients with mild to moderate aortic stenosis and preserved left ventricular function","volume":"52","author":"Zhao","year":"2004","journal-title":"J. Investig. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1054-8807(00)00043-0","article-title":"Matrix metalloproteinase expression in nonrheumatic aortic stenosis","volume":"9","author":"Edep","year":"2000","journal-title":"Cardiovasc. Pathol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1093\/eurheartj\/ehi248","article-title":"Extracellular matrix remodelling in human aortic valve disease: The role of matrix metalloproteinases and their tissue inhibitors","volume":"26","author":"Fondard","year":"2005","journal-title":"Eur. Heart J."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0002-9440(10)61698-7","article-title":"Matrix metalloproteinase-2 is associated with tenascin-C in calcific aortic stenosis","volume":"159","author":"Jian","year":"2001","journal-title":"Am. J. Pathol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1161\/01.CIR.103.11.1522","article-title":"Bone formation and inflammation in cardiac valves","volume":"103","author":"Mohler","year":"2001","journal-title":"Circulation"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.4065\/79.10.1239","article-title":"Electron beam computed tomography: The latest \u201cstethoscope\u201d for calcific aortic valve disease","volume":"79","author":"Novaro","year":"2004","journal-title":"Mayo Clin. Proc."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1001\/archinte.165.8.858","article-title":"Angiotensin-converting enzyme inhibitors and change in aortic valve calcium","volume":"165","author":"Probstfield","year":"2005","journal-title":"Arch Intern Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/j.jacc.2004.07.054","article-title":"Induction of local angiotensin II-producing systems in stenotic aortic valves","volume":"44","author":"Helske","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1161\/01.CIR.0000035655.45453.D2","article-title":"Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma","volume":"106","author":"Shavelle","year":"2002","journal-title":"Circulation"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1161\/01.CIR.90.2.844","article-title":"Characterization of the early lesion of \u2018degenerative\u2019 valvular aortic stenosis. Histological and immunohistochemical studies","volume":"90","author":"Otto","year":"1994","journal-title":"Circulation"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1136\/hrt.2004.036848","article-title":"Atherosclerosis-like lesions of the aortic valve are common in adults of all ages: A necropsy study","volume":"91","author":"Kuusisto","year":"2005","journal-title":"Heart"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(09)60211-7","article-title":"Aortic stenosis","volume":"373","author":"Carabello","year":"2009","journal-title":"Lancet"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0735-1097(02)02622-0","article-title":"Aortic valve sclerosis is associated with systemic endothelial dysfunction","volume":"41","author":"Poggianti","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0002-9149(00)00830-4","article-title":"Nonobstructive aortic valve calcium as a window to atherosclerosis of the aorta","volume":"86","author":"Adler","year":"2000","journal-title":"Am. J. Cardiol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.amjcard.2003.10.035","article-title":"Association of aortic valve calcium detected by electron beam computed tomography with echocardiographic aortic valve disease and with calcium deposits in the coronary arteries and thoracic aorta","volume":"93","author":"Walsh","year":"2004","journal-title":"Am. J. Cardiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1056\/NEJM199907153410310","article-title":"Aortic sclerosis\u2014A window to the coronary arteries?","volume":"341","author":"Carabello","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/clc.4960261207","article-title":"Association of aortic valve sclerosis and coronary artery disease in patients with severe nonischemic mitral regurgitation","volume":"26","author":"Rossi","year":"2003","journal-title":"Clin. Cardiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.ahj.2004.05.048","article-title":"Epidemiology of mitral annular calcification and its predictive value for coronary events in African Americans: The Jackson Cohort of the Atherosclerotic Risk in Communities Study","volume":"148","author":"Fox","year":"2004","journal-title":"Am. Heart J."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1161\/01.CIR.0000058168.26163.BC","article-title":"Mitral annular calcification predicts cardiovascular morbidity and mortality: The Framingham Heart Study","volume":"107","author":"Fox","year":"2003","journal-title":"Circulation"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0002-9149(84)90704-5","article-title":"Cardiac conduction defects in patients older than 60 years with aortic stenosis with and without mitral anular calcium","volume":"53","author":"Nair","year":"1984","journal-title":"Am. J. Cardiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/0002-9149(87)91038-1","article-title":"Calcific valvular aortic stenosis with and without mitral anular calcium","volume":"60","author":"Nair","year":"1987","journal-title":"Am. J. Cardiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0140-6736(86)90530-1","article-title":"Aortic calcification as a predictor of cardiovascular mortality","volume":"2","author":"Witteman","year":"1986","journal-title":"Lancet"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/S0002-9149(00)01167-X","article-title":"Relation of nonobstructive aortic valve calcium to carotid arterial atherosclerosis","volume":"86","author":"Adler","year":"2000","journal-title":"Am. J. Cardiol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1476-7120-2-19","article-title":"Association of mitral annulus calcification, aortic valve calcification with carotid intima media thickness","volume":"2","author":"Sgorbini","year":"2004","journal-title":"Cardiovasc. Ultrasound"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.amjcard.2004.06.015","article-title":"Relation of aortic valve sclerosis to carotid artery intima-media thickening in healthy subjects","volume":"94","author":"Yamaura","year":"2004","journal-title":"Am. J. Cardiol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7863\/jum.2005.24.4.461","article-title":"Prognostic value of carotid intima-media thickness in detection of coronary atherosclerosis in patients with calcified aortic valve stenosis","volume":"24","author":"Przewlocki","year":"2005","journal-title":"J. Ultrasound Med."},{"key":"ref_78","first-page":"85","article-title":"Debljina intima-medija kompleksa zajednicke karotidne arterije, karotidna ateroskleroza i suptipovi ishemicnog mozdanog udara Common carotid artery intima-media thickness, carotid atherosclerosis and subtypes of ischemic cerebral disease","volume":"56","year":"2003","journal-title":"Med. Pregl."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jacc.2003.10.027","article-title":"Why is aortic sclerosis associated with adverse clinical outcomes?","volume":"43","author":"Otto","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jacc.2008.05.043","article-title":"Dysregulation of antioxidant mechanisms contributes to increased oxidative stress in calcific aortic valvular stenosis in humans","volume":"52","author":"Miller","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1093\/eurheartj\/eht034","article-title":"Aortic stenosis, atherosclerosis, and skeletal bone: Is there a common link with calcification and inflammation?","volume":"34","author":"Dweck","year":"2013","journal-title":"Eur. Heart J."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1161\/CIRCULATIONAHA.110.006767","article-title":"Calcific aortic valve disease: Not simply a degenerative process","volume":"124","author":"Rajamannan","year":"2011","journal-title":"Circulation"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000485074","article-title":"Osteocardiology: Defining the go\/no-go time point for therapy","volume":"139","author":"Rajamannan","year":"2018","journal-title":"Cardiology"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1148\/radiol.2021202630","article-title":"Association between Aortic Valve Calcification Progression and Coronary Atherosclerotic Plaque Volume Progression in the PARADIGM Registry","volume":"300","author":"Lee","year":"2021","journal-title":"Radiology"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1161\/01.CIR.0000140722.85490.EA","article-title":"Targeted therapy to prevent progression of calcific aortic stenosis","volume":"110","author":"Rajamannan","year":"2004","journal-title":"Circulation"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/clc.4960240109","article-title":"Association between calcific aortic stenosis and hypercholesterolemia: Is there a need for a randomized controlled trial of cholesterol-lowering therapy?","volume":"24","author":"Chui","year":"2001","journal-title":"Clin. Cardiol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1161\/hc4301.098249","article-title":"Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis","volume":"104","author":"Novaro","year":"2001","journal-title":"Circulation"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/107424840300800305","article-title":"Anti-inflammatory effects of statins in patients with aortic stenosis","volume":"8","author":"Pate","year":"2003","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"ref_89","first-page":"119","article-title":"Progression of aortic valve sclerosis and aortic valve stenosis: What is the role of statin treatment?","volume":"6","author":"Popescu","year":"2005","journal-title":"Ital. Heart J."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0140-6736(02)08161-8","article-title":"HMG CoA reductase inhibitor (statin) and aortic valve calcium","volume":"359","author":"Shavelle","year":"2002","journal-title":"Lancet"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/S0735-1097(02)02496-8","article-title":"Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community","volume":"40","author":"Bellamy","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/S0735-1097(02)02497-X","article-title":"Medical treatment of aortic stenosis: Promising, or wishful thinking?","volume":"40","author":"Pearlman","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/hrt.2003.029785","article-title":"Atorvastatin inhibits calcification and enhances nitric oxide synthase production in the hypercholesterolaemic aortic valve","volume":"91","author":"Rajamannan","year":"2005","journal-title":"Heart"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1056\/NEJMc051838","article-title":"Lipid-lowering therapy in calcific aortic stenosis","volume":"353","author":"Chan","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1136\/hrt.2005.069815","article-title":"Tissue resident C reactive protein in degenerative aortic valves: Correlation with serum C reactive protein concentrations and modification by statins","volume":"92","author":"Skowasch","year":"2006","journal-title":"Heart"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa0804602","article-title":"Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis","volume":"359","author":"Pedersen","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMoa043876","article-title":"Scottish Aortic Stenosis and Lipid Lowering Trial, Impact on Regression (SALTIRE) Investigators: A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis","volume":"352","author":"Cowell","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1056\/NEJMe058070","article-title":"Statins for aortic stenosis","volume":"352","author":"Rosenhek","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jacc.2006.07.072","article-title":"Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis","volume":"49","author":"Moura","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1161\/CIRCULATIONAHA.108.834614","article-title":"Lowering plasma cholesterol levels halts progression of aortic valve disease in mice","volume":"119","author":"Miller","year":"2009","journal-title":"Circulation"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.atherosclerosis.2016.01.023","article-title":"The effect of statins on valve function and calcification in aortic stenosis: A meta-analysis","volume":"246","author":"Zhao","year":"2016","journal-title":"Atherosclerosis"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.jcmg.2018.04.015","article-title":"Effects of Statins on Coronary Atherosclerotic Plaques: The PARADIGM Study","volume":"11","author":"Lee","year":"2018","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.jacc.2015.01.036","article-title":"Impact of statins on serial coronary calcification during atheroma progression and regression","volume":"65","author":"Puri","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1161\/01.CIR.94.11.2756","article-title":"Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease","volume":"94","author":"Diet","year":"1996","journal-title":"Circulation"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1161\/01.CIR.98.8.800","article-title":"Evidence that macrophages in atherosclerotic lesions contain angiotensin, II","volume":"98","author":"Potter","year":"1998","journal-title":"Circulation"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/sj.jhh.1001714","article-title":"Effect of the renin-angiotensin system on the vessel wall: Using ACE inhibition to improve endothelial function","volume":"18","author":"Neutel","year":"2004","journal-title":"J. Hum. Hypertens."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1161\/01.CIR.101.12.1372","article-title":"Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: Potential implications for inflammation and plaque instability","volume":"101","author":"Schieffer","year":"2000","journal-title":"Circulation"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1161\/01.CIR.0000140723.15274.53","article-title":"Statins but not angiotensin- converting enzyme inhibitors delay progression of aortic stenosis","volume":"110","author":"Rosenhek","year":"2004","journal-title":"Circulation"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1016\/j.jacc.2021.09.1367","article-title":"Evaluating Medical Therapy for Calcific Aortic Stenosis: JACC State-of-the-Art Review","volume":"78","author":"Lindman","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1210\/jc.2016-1206","article-title":"PCSK9 R46L Loss-of-Function Mutation Reduces Lipoprotein(a), LDL Cholesterol, and Risk of Aortic Valve Stenosis","volume":"101","author":"Langsted","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1016\/j.jacc.2010.02.044","article-title":"PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses","volume":"55","author":"Benn","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/jamacardio.2020.0728","article-title":"An exploratory analysis of proprotein convertase subtilisin\/kexin type 9 inhibition and aortic stenosis in the FOURIER trial","volume":"6","author":"Bergmark","year":"2020","journal-title":"JAMA Cardiol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.jacbts.2020.05.004","article-title":"Genetic and In Vitro Inhibition of PCSK9 and Calcific Aortic Valve Stenosis","volume":"5","author":"Perrot","year":"2020","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Xiao, F., Zha, Q., Zhang, Q., Wu, Q., Chen, Z., Yang, Y., Yang, K., and Liu, Y. (2021). Decreased Glucagon-Like Peptide-1 Is Associated With Calcific Aortic Valve Disease: GLP-1 Suppresses the Calcification of Aortic Valve Interstitial Cells. Front. Cardiovasc. Med., 8.","DOI":"10.3389\/fcvm.2021.709741"},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Zhou, Y., Yuan, Z., Wang, M., Zhang, Z., Tan, C., Yu, J., Bi, Y., Liao, X., Zhou, X., and Ali Sheikh, M.S. (2023). Liraglutide Attenuates Aortic Valve Calcification in a High-Cholesterol-Diet-Induced Experimental Calcific Aortic Valve Disease Model in Apolipoprotein E-Deficient Mice. J. Cardiovasc. Dev. Dis., 10.","DOI":"10.3390\/jcdd10090386"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Mazur, P., Kopytek, M., Z\u0105bczyk, M., Undas, A., and Natorska, J. (2021). Towards Personalized Therapy of Aortic Stenosis. J. Pers. Med., 11.","DOI":"10.3390\/jpm11121292"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ijcard.2018.11.119","article-title":"Cardiac valve calcification and use of anticoagulants: Preliminary observation of a potentially modifiable risk factor","volume":"278","author":"Tripepi","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"106679","DOI":"10.1016\/j.vph.2020.106679","article-title":"Effects of rivaroxaban and dabigatran on local expression of coagulation and inflammatory factors within human aortic stenotic valves","volume":"130","author":"Iwaniec","year":"2020","journal-title":"Vasc. Pharmacol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"432080","DOI":"10.1155\/2011\/432080","article-title":"Evaluation of plaque stability of advanced atherosclerotic lesions in apo E-deficient mice after treatment with the oral factor Xa inhibitor rivaroxaban","volume":"2011","author":"Zhou","year":"2011","journal-title":"Mediat. Inflamm."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1124\/jpet.112.194837","article-title":"The effects of direct thrombin inhibition with dabigatran on plaque formation and endothelial function in apolipoprotein E-deficient mice","volume":"343","author":"Lee","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s10557-012-6411-3","article-title":"The beneficial effects of a direct thrombin inhibitor, dabigatran etexilate, on the development and stability of atherosclerotic lesions in apolipoprotein E-deficient mice: Dabigatran etexilate and atherosclerosis","volume":"26","author":"Kadoglou","year":"2012","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.atherosclerosis.2015.03.023","article-title":"Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice","volume":"242","author":"Hara","year":"2015","journal-title":"Atherosclerosis"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/jth.15289","article-title":"Off-target effects of oral anticoagulants-vascular effects of vitamin K antagonist and non-vitamin K antagonist oral anticoagulant dabigatran etexilate","volume":"19","author":"Dijkgraaf","year":"2021","journal-title":"J. Thromb. Haemost."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejphar.2013.09.006","article-title":"Coagulation factor Xa induces an inflammatory signalling by activation of protease-activated receptors in human atrial tissue","volume":"718","author":"Bukowska","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"ref_126","first-page":"8129513","article-title":"Advantages and Disadvantages of Inclisiran: A Small Interfering Ribonucleic Acid Molecule Targeting PCSK9-A Narrative Review","volume":"2022","author":"Reiner","year":"2022","journal-title":"Cardiovasc. Ther."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/8\/1375\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:18:31Z","timestamp":1760033911000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/8\/1375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,30]]},"references-count":126,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["medicina61081375"],"URL":"https:\/\/doi.org\/10.3390\/medicina61081375","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,30]]}}}